FDA reveals further steps to encourage generic competition
03-01-2018
FDA to increase drug competition and speed up ANDA reviews
28-06-2017
The US Food and Drug Administration (FDA) has issued new guidance as part of its bid to target the barriers to generic drug competition.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Food and Drug Administration, FDA, Scott Gottlieb, generics, competition, drug pricing, ANDA
